✦ LIBER ✦

P1534 Comparison of sulbactam/ampicillin and tazobactam/piperacillin for the treatment of lower respiratory tract infection in paediatric patients

✍ Scribed by Ishiwada, N.; Hoshino, T.; Kohno, Y.

Book ID: 123223675
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 59 KB
Volume: 29
Category: Article
ISSN: 0924-8579
DOI: 10.1016/S0924-8579(07)71373-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Role of sultamicillin and ampicillin/sul

Role of sultamicillin and ampicillin/sulbactam in the treatment of upper and lower bacterial respiratory tract infections

✍ H Lode 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Intravenous ampicillin/sulbactam versus

Intravenous ampicillin/sulbactam versus cefuroxime axetil in the treatment of patients hospitalized with community-acquired lower respiratory tract infections

✍ Leonard J. Rossoff; Eileen Hilton; Candace Smith; Henry D. Isenberg; Maureen McK 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 763 KB

Comparison of sulbactam/ampicillin and c

Comparison of sulbactam/ampicillin and cefuroxime in infections of the lower respiratory tract: results of a prospective, randomized and comparative study

✍ C.-D. Schwigon; R. Cuhorst; M. Gabor; J. Zinndorf; M. Springsklee 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 532 KB

Comparison of azithromycin versus clarit

Comparison of azithromycin versus clarithromycin in the treatment of patients with lower respiratory tract infection

✍ Bradbury, F. 📂 Article 📅 1993 🏛 Oxford University Press 🌐 English ⚖ 529 KB

Comparison of nasal prongs and nasophary

Comparison of nasal prongs and nasopharyngeal catheter for the delivery of oxygen in children with hypoxemia because of a lower respiratory tract infection

✍ Martin W. Weber; Ayo Palmer; Anslem Oparaugo; E.Kim Mulholland 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 580 KB

Correcting for bias when estimating the

Correcting for bias when estimating the cost of hospital-acquired infection: an analysis of lower respiratory tract infections in non-surgical patients

✍ Nicholas Graves; Diana Weinhold; Jennifer A. Roberts 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 1 views

Hospital acquired infections (HAI) are costly but many are avoidable. Evaluating prevention programmes requires data on their costs and benefits. Estimating the actual costs of HAI (a measure of the cost savings due to prevention) is difficult as HAI changes cost by extending patient length of stay,